Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy
Số trang: 14
Loại file: pdf
Dung lượng: 2.40 MB
Lượt xem: 7
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
The association between specific genetic mutations and immunotherapy benefits has been widely known, while such studies in pan-cancer are still limited. SPEN, mainly involved in X chromosome inactivation (XCI), plays an essential in tumorigenesis and sex differences in cancer.
Nội dung trích xuất từ tài liệu:
Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy
Nội dung trích xuất từ tài liệu:
Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy
Tìm kiếm theo từ khóa liên quan:
BMC Cancer X chromosome inactivation Immune checkpoint inhibitor T-lymphocyte-associated antigen 4 Microsatellite instabilityTài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 120 0 0 -
12 trang 93 0 0
-
19 trang 74 0 0
-
17 trang 64 0 0
-
9 trang 43 0 0
-
12 trang 38 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 38 0 0